Author Correction: Targeting public neoantigens for cancer immunotherapy

被引：0
|
作者：
Alexander H. Pearlman
Michael S. Hwang
Maximilian F. Konig
Emily Han-Chung Hsiue
Jacqueline Douglass
Sarah R. DiNapoli
Brian J. Mog
Chetan Bettegowda
Drew M. Pardoll
Sandra B. Gabelli
Nicholas Papadopoulos
Kenneth W. Kinzler
Bert Vogelstein
Shibin Zhou
机构：
[1] The Johns Hopkins University School of Medicine,Ludwig Center, Sidney Kimmel Comprehensive Cancer Center
[2] The Johns Hopkins University School of Medicine,Lustgarten Pancreatic Cancer Research Laboratory, Sidney Kimmel Comprehensive Cancer Center
[3] Howard Hughes Medical Institute,Division of Rheumatology, Department of Medicine
[4] The Johns Hopkins University School of Medicine,Department of Biomedical Engineering
[5] Johns Hopkins University,Department of Neurosurgery
[6] The Johns Hopkins University School of Medicine,Department of Oncology
[7] The Johns Hopkins University School of Medicine,Bloomberg~Kimmel Institute for Cancer Immunotherapy
[8] Sidney Kimmel Comprehensive Cancer Center,Department of Biophysics and Biophysical Chemistry
[9] The Johns Hopkins University School of Medicine,Department of Medicine
[10] The Johns Hopkins University School of Medicine,Department of Pathology
[11] The Johns Hopkins University School of Medicine,Sol Goldman Pancreatic Cancer Research Center
[12] The Johns Hopkins University School of Medicine,undefined
[13] Genentech,undefined
[14] Inc.,undefined
来源：
Nature Cancer | 2021年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：865 / 867
页数：2
相关论文
共 50 条
  • [41] Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy
    Kuai, Rui
    Sun, Xiaoqi
    Yuan, Wenmin
    Xu, Yao
    Schwendeman, Anna
    Moon, James J.
    BIOCONJUGATE CHEMISTRY, 2018, 29 (03) : 771 - 775
  • [42] Targeting neoantigens
    Bernard, Nick
    NATURE IMMUNOLOGY, 2022, 23 (10) : 1399 - 1399
  • [43] Tumor neoantigens: building a framework for personalized cancer immunotherapy
    Gubin, Matthew M.
    Artyomov, Maxim N.
    Mardis, Elaine R.
    Schreiber, Robert D.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09): : 3413 - 3421
  • [44] Chemically inducible splice-neoantigens for cancer immunotherapy
    Matsushima, Shingo
    Ajiro, Masahiko
    Iida, Kei
    Chamoto, Kenji
    Honjo, Tasuku
    Hagiwara, Masatoshi
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Immune targets and neoantigens for cancer immunotherapy and precision medicine
    Rong-Fu Wang
    Helen Y Wang
    Cell Research, 2017, 27 : 11 - 37
  • [46] IMMUNOGENIC LANDSCAPE AND THERAPEUTIC TARGETING OF MUTANT NRAS "PUBLIC" NEOANTIGENS
    Etxeberria, Inaki
    Banks, Lauren
    Chandran, Smita
    Correa, Arianna
    Novak, Bryan
    Fleischman, Jessica
    Drilon, Alexander
    Wolchok, Jedd
    Merghoub, Taha
    Klebanoff, Christopher
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A232 - A232
  • [47] Identification of neoantigens for immunotherapy
    Braeunlein, Eva
    Krackhardt, Angela M.
    ONKOLOGE, 2021, 27 (11): : 1109 - 1113
  • [48] Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Etxeberria, Inaki
    Perera, Gihan
    Lyudovyk, Olga
    Chandran, Smita
    Banks, Lauren
    Gormally, Michael
    Postow, Michael
    Merghoub, Taha
    Wolchok, Jedd
    Greenbaum, Benjamin
    Baker, Brian
    Klebanoff, Christopher
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [49] Enhanced detection of T-cells targeting unique neoantigens and shared mutated oncogenes for personalized cancer immunotherapy
    Yossef, Rami
    Tran, Eric
    Gros, Alena
    Deniger, Drew
    Cafri, Gal
    Rosenberg, Steven A.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [50] Neoantigens in precision cancer immunotherapy: from identification to clinical applications
    Zhang, Qiao
    Jia, Qingzhu
    Zhang, Jing
    Zhu, Bo
    CHINESE MEDICAL JOURNAL, 2022, 135 (11) : 1285 - 1298
12345